STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class
The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.